Atlas Trials

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis

Clinical trial NCT00670319 · COMPLETED

Trial details

NCT number
NCT00670319
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Osteoporosis, Postmenopausal
Start date
1994-11-01
Primary completion
1999-09-01
Enrollment
7705

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.